Ben-Gurion University of the Negev Research and Development Authority

Hadasit Medical Research Services and Development Ltd.

Immuron Limited

Ami Ben-Yaakov

Yaron Ilan

Smadar Cohen

Gadi Lalazar

Eyal Shteyer

Tsiona Elkayam

Tomer Adar

Gad Lalazar

The present invention relates to methods for the treatment of hepatic disorders in a subject in need thereof. More specifically, the methods of the invention are based on the administration, preferably, systemic administration, of a therapeutically effective amount of at least one biocompatible alginate biomaterial, any modification thereof and any combination thereof. The invention further provides methods for sustaining serum albumin levels, and/or reducing serum AST and ALT, in subjects suffering from hepatic disorder. Still further, the invention provides methods for reducing apoptosis and inducing cell proliferation in a damaged liver tissue of a subject suffering of hepatic disorder, using the alginate biomaterial described by the invention.

Alginate biomaterials for the treatment of hepatic disorders

Growing community of inventors

Jerusalem, Israel

Ami Ben-Yaakov